Rethinking of cytotoxic/immunosuppressive chemotherapy mixing with immune-based therapeutics.
Investors’ Soapbox PM
Cancer therapy may see major shift.
There’s evidence cytotoxic/immunosuppressive chemotherapy can be combined with immune-based therapeutics.
Read more